Being a student is special. The best students are full of life and energy, eager to grasp new concepts and not afraid of stumbling on the way to a fuller understanding. The most important thing to do as a mentor is keep this spirit alive and continue to cultivate it organically. That is why I like to treat my lab as a startup run by students. They’re running the show, making decisions, and free to take the enterprise in whichever direction they think is best.
EIPM Researcher Wins Pershing Square Sohn Prize
June 1, 2021
Dr. Marcin Imielinski, an assistant professor of pathology and laboratory medicine [and a Member of the Englander Institute for Precision Medicine], and Dr.
EIPM Director’s June 2021 Newsletter
June 1, 2021
Dear Members of the Englander Institute,
I hope you enjoy this month’s newsletter, which is packed with a remarkable number of news stories about the work of our colleagues, their awards, events and publications. I’m so proud of these achievements, and I hope you are as well.
I’d like to welcome the newest member of our team, computational biologist Peter Waltman, Ph.D., who will be working in my lab and in the lab of Dr. Andrea Sboner, our Director of Informatics and Computational Biology.
A Conversation with Dr. Peter Waltman
May 25, 2021
We are pleased to introduce our newest EIPM Member Peter Waltman, Ph.D.
Dr. Waltman is a Research Associate in Bioinformatics at the Englander Institute for Precision Medicine, working in the labs of Director Olivier Elemento, Ph.D., and Andrea Sboner, Ph.D., our Director of Informatics and Computational Biology.
We hope you enjoy learning more about his research interests and background.
Q: What makes your research unique? Can you share some recent findings?
Predicting How Prostate Cancer Will Behave
May 17, 2021
Molecular characteristics detected in prostate cancers can provide clues that help predict how the disease will progress, according to new research from investigators at Weill Cornell Medicine and NewYork-Presbyterian.
New Grants to Increase Access to Care in Queens & Brooklyn
May 6, 2021
Two Grants Aim to Increase Access to Care and Clinical Trials for Queens and Brooklyn Patients with Blood Cancers
Weill Cornell Medicine has received complementary grants from Genentech and the Leukemia & Lymphoma Society (LLS) to support a new program that aims to address socioeconomic and racial disparities and increase access to clinical trials for underserved patients with blood cancers living in Brooklyn and Queens.
Exploring the Role of Proteins in Obesity
April 26, 2021
A study of proteins circulating in the bloodstream has identified several proteins that may play a causal role in obesity, making them potential targets for drugs and therapies.
Researchers at Weill Cornell Medicine – Qatar examined more than 1,000 proteins in samples taken from individuals in Qatar as part of the Qatar Metabolomics Study on Diabetes, alongside data from European studies. In total, more than 4,600 individuals were involved in the three previous studies. The work was conducted in collaboration with the German Research Center for Environmental Health.
Genomic sequencing in diverse populations
April 13, 2021
Opening Plenary highlights bench-to-bedside aspects of research and clinical treatment
The American Association for Cancer Research Annual Meeting’s Opening Plenary Session: Discovery Science Driving Clinical Breakthroughs featured a broad range of topics—from cutting-edge cell tracking research to advances in our understanding of tumor metabolism to clinical targeting in ethnically diverse populations—illustrating the
Research Unlocks a New Discovery about Controlling Genes
April 9, 2021
Stem Cell Research Unlocks a New Discovery about Controlling Genes
The DNA in our genes contains the instructions needed to manufacture all of the proteins in our cells. These proteins, in turn, do the work that keeps our bodies functioning. Therefore, knowing how individual proteins get made can help us understand the causes of human disease, including cancer.
2021 Quarterly External Newsletter
April 5, 2021
SPRING 2021 NEWSLETTER
Dear friend of the Englander Institute for Precision Medicine,